Fair Value Measurements (Tables)

12 Months Ended

Jul. 31, 2019

Schedule of fair values of financial instruments measured on a recurring basis

The fair values of our financial instruments measured on a recurring basis were categorized as follows:



	July 31, 2019
	Level 1		Level 2		Level 3		Total
Assets:
Cash and cash equivalents:
Money markets	$	104	$	—	$	—	$	104
Prepaid expenses and other current assets:
Interest rate swap	—		486		—		486
Other Assets:
Interest rate swap	—		2,826		—		2,826
Total assets	$	104	$	3,312	$	—	$	3,416
Liabilities:
Other long-term liabilities:
Contingent consideration	—		—		1,411		1,411
Total liabilities	$	—	$	—	$	1,411	$	1,411



	July 31, 2018
	Level 1		Level 2		Level 3		Total
Assets:
Cash and cash equivalents:
Money markets	$	104	$	—	$	—	$	104
Total assets	$	104	$	—	$	—	$	104
Liabilities:
Other long-term liabilities:
Contingent consideration	—		—		1,298		1,298
Total liabilities	$	—	$	—	$	1,298	$	1,298

Reconciliation of liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3)

A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for fiscal 2019, 2018 and 2017 is as follows:



	Aexis Medical Contingent Consideration		Jet Prep Assumed Contingent Obligation			Cantel Medical (U.K.) Contingent Guaranteed Obligation			Total
Balance, August 1, 2016	$	—	$	1,138		$	441		$	1,579
Income included in general and administrative expenses	—		—			(265		)	(265		)
Net purchases, issuances, sales and settlements	—		—			(176		)	(176		)
Balance, July 31, 2017	—		1,138			—			1,138
Original fair value of contingent consideration	1,292		—			—			1,292
Loss included in general and administrative expenses	6		—			—			6
Net purchases, issuances, sales and settlements	—		(1,138		)	—			(1,138		)
Balance, July 31, 2018	1,298		—			—			1,298
Loss included in general and administrative expense	113		—			—			113
Balance, July 31, 2019	$	1,411	$	—		$	—		$	1,411